Lupin Stock

Lupin EBIT

The EBIT of Lupin (LUPIN.NS) as of Aug 12, 2026 is 42.17 B INR. In the previous year, EBIT was 28.09 B INR — a change of 50.12% (higher).

EBIT

42.17 BINR

YoY

50.12%

Last updated:

In 2026, Lupin's EBIT was 42.17 B INR, a 50.12% increase from the 28.09 B INR EBIT recorded in the previous year.

The Lupin EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (B INR)
Date
EBIT (B INR)
Jan 1, 2022
13.25 base
Jan 1, 2023
9.21 base
Jan 1, 2024
28.09 base
Jan 1, 2025
42.17 base
Jan 1, 2026 (e)
38.58 base
Jan 1, 2027 (e)
42.45 base
Jan 1, 2028 (e)
44.57 base
Jan 1, 2029 (e)
49.00 base
YEAREBIT (B INR)
2029 est 49.00
2028 est 44.57
2027 est 42.45
2026 est 38.58
2025 42.17
2024 28.09
2023 9.21
2022 13.25
2021 16.91
2020 14.12
2019 17.25
2018 20.65
2017 35.99
2016 32.38
2015 33.13
2014 28.45
2013 20.02
2012 12.57
2011 10.17
2010 8.84
2009 6.81
2008 5.88
2007 4.45
2006 2.57
Access this data via the Eulerpool API

Lupin Revenue

Lupin Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
164.05 B INR
13.25 B INR
-15.28 B INR
Jan 1, 2023
166.42 B INR
9.21 B INR
4.30 B INR
Jan 1, 2024
200.11 B INR
28.09 B INR
19.14 B INR
Jan 1, 2025
227.08 B INR
42.17 B INR
32.82 B INR
Jan 1, 2026 (e)
271.26 B INR
38.58 B INR
50.26 B INR
Jan 1, 2027 (e)
298.50 B INR
42.45 B INR
45.88 B INR
Jan 1, 2028 (e)
313.40 B INR
44.57 B INR
47.34 B INR
Jan 1, 2029 (e)
344.53 B INR
49.00 B INR
54.90 B INR

Lupin Margins

Lupin stock margins

The Lupin margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Lupin. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Lupin.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2022
54.37 %
8.07 %
-9.31 %
Jan 1, 2023
53.71 %
5.53 %
2.58 %
Jan 1, 2024
61.84 %
14.04 %
9.57 %
Jan 1, 2025
65.16 %
18.57 %
14.45 %
Jan 1, 2026 (e)
65.16 %
14.22 %
18.53 %
Jan 1, 2027 (e)
65.16 %
14.22 %
15.37 %
Jan 1, 2028 (e)
65.16 %
14.22 %
15.10 %
Jan 1, 2029 (e)
65.16 %
14.22 %
15.93 %

Lupin Stock analysis

What does Lupin do? Lupin Limited is an Indian pharmaceutical company specializing in generics and novel therapies. It was founded in 1968 by Dr. Desh Bandhu Gupta and has experienced rapid growth, becoming one of the leading companies in the global pharmaceutical market. The company's business model involves manufacturing and marketing generics and novel therapies for the treatment of various diseases such as cancer, diabetes, cardiovascular diseases, and respiratory diseases. Lupin operates worldwide with a wide range of partners to distribute its products in over 100 countries. The company is involved in various divisions including generics, novel therapies, biosimilars, and inhalation products. Lupin's generics division encompasses a wide range of products such as antibiotics, antidepressants, antihypertensives, and many other categories. Its novel therapies include innovative products for the treatment of diabetes, cancer, multiple sclerosis, and other chronic diseases. Lupin is also involved in the development of biosimilars, which are imitation biopharmaceuticals manufactured using living organisms. Lastly, the company offers inhalation products for the treatment of respiratory diseases such as asthma and COPD. Lupin has built an impressive product pipeline over the years, having submitted over 174 ANDA applications (for the approval of new generics) to the US FDA and introduced more than 80 new products in the Indian market. It has also established an innovative research and development center that focuses on the discovery of new molecules and the development of new therapeutic approaches. Another important feature of Lupin is its commitment to quality and sustainability. The company has received numerous awards for its product quality and environmental initiatives. In 2019, Lupin received the Sustainable Business Award from CNBC TV18. Overall, Lupin Limited is a successful and fast-growing company specializing in generics and novel therapies. It has a wide range of products and an impressive pipeline, and operates globally. Due to its commitment to quality and sustainability, Lupin Limited has also built a strong reputation among its customers and partners. Lupin is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Lupin's EBIT

Lupin's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Lupin's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Lupin's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Lupin’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Lupin stock

EBIT of Lupin is 42.17 B INR in 2026.

EBIT of Lupin changed from 28.09 B INR to 42.17 B INR, representing a 50.12% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Lupin since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Lupin historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Lupin

All Key Metrics — Lupin